Accepted for Publication: July 11, 2015.
Published Online: October 19, 2015. doi:10.1001/jamapediatrics.2015.2380.
Study concept and design: Ericson, Popoola, Smith, Daniel K. Benjamin Jr, Clark, Milstone.
Acquisition, analysis, or interpretation of data: Ericson, Popoola, Daniel K. Benjamin, Fowler, Clark, Milstone.
Drafting of the manuscript: Ericson, Daniel K. Benjamin Jr, Clark, Milstone.
Critical revision of the manuscript for important intellectual content: Ericson, Popoola, Smith, Daniel K. Benjamin, Fowler, Clark, Milstone.
Statistical analysis: Ericson, Popoola, Daniel K. Benjamin.
Obtained funding: Daniel K. Benjamin Jr.
Administrative, technical, or material support: Clark.
Study supervision: Smith, Clark, Milstone.
Conflict of Interest Disclosures: Drs Smith and Daniel K. Benjamin Jr reported receiving research support from Cempra Pharmaceuticals (subaward to HHS0100201300009C) and industry for neonatal and pediatric drug development (http://www.dcri.duke.edu/research/coi.jsp). Dr Fowler reported receiving grant or research support from Advanced Liquid Logic, Cubist, Cerexa, MedImmune, Merck, National Institutes of Health (NIH), Novartis, Pfizer, and Theravance; reported being a paid consultant to Affinium, Basilea, Baxter, Cerexa, Cubist, Debiopharm, Durata, Merck, Novartis, NovaDigm, The Medicines Company, MedImmune, Pfizer, Theravance, and Trius; reported receiving honoraria from Arpida, Astellas, Cubist, Inhibitex, Merck, Pfizer, Targanta, Theravance, Wyeth, Ortho-McNeil, Novartis, and Vertex Pharmaceuticals; and reported being a member of the Merck V710 Vaccine Scientific Advisory Board. Dr Milstone reported receiving grant support from Sage Products LLC. No other disclosures were reported.
Funding/Support: Dr Ericson is supported by grant 5T32HD060558 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the NIH. Dr Smith is supported by grant UL1TR001117 from the National Center for Advancing Translational Sciences of the NIH, by grants HHSN275201000003I and 1R01-HD081044-01 from the NICHD, and by grant 1R18-FD005292-01 from the US Food and Drug Administration. Dr Fowler is supported by grants K24-AI093969 and R01-AI068804 from the NIH and by grant UM1AI104681 from the NIH Antibiotic Resistant Leadership Group. Dr Daniel K. Benjamin Jr is supported by grant 2K24HD058735-06 from the NIH, by grant UL1TR001117 from the National Center for Advancing Translational Sciences, by contract HHSN275201000003I from the NICHD, and by contract HHSN272201500006I from the National Institute of Allergy and Infectious Diseases (NIAID). Dr Milstone is supported by grant R03AI117169 from the NIAID and by grant R01HS022872 from the Agency for Healthcare and Research Quality.
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.